A cuproptosis-related prognostic signature for guiding clinical diagnosis and treatment in uveal melanoma patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ying,Yang

第一单位： Eye Institute, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China.;Medical School of Nantong University, Nantong, Jiangsu, China.

作者： Ying,Yang ^[1] ; Qixuan,Li ^[2] ; Jia,Chen ^[3] ; Yangchen,Guo ^[4] ; Yu,Cai ^[1] ; Wenmin,Zhao ^[5] ; Shu,Su ^[3] ; Aimin,Sang ^[3]

作者单位： Eye Institute, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China.;Medical School of Nantong University, Nantong, Jiangsu, China. ^[1] Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China.;Medical School of Nantong University, Nantong, Jiangsu, China. ^[2] Eye Institute, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China. ^[3] Medical School of Nantong University, Nantong, Jiangsu, China. ^[4] Medical School of Nantong University, Nantong, Jiangsu, China.;Department of Dermatology, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China. ^[5]

关键词 Cuproptosis DLD DLST Immune microenvironment Prognostic signature Uveal melanoma (UM)

DOI 10.1016/j.heliyon.2024.e36324

PMID 39247274

发布时间 2024-09-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Heliyon

2024年10卷16期

e36324页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A cuproptosis-related prognostic signature for guiding clinical diagnosis and treatment in uveal melanoma patients.

Heliyon

相似文献

Heliyon

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A cuproptosis-related prognostic signature for guiding clinical diagnosis and treatment in uveal melanoma patients.

Heliyon

相似文献

Heliyon

相关期刊

检索历史清除